The Business Research Company’s report on the Migraine Treatment Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the primary drivers fueling the growth of the migraine treatment market in recent years?
The prolonged screen exposure is expected to propel the growth of the migraine treatment market. Screen exposure refers to the amount of time individuals spend interacting with electronic screens, such as those on smartphones, tablets, computers, and televisions. Prolonged screen exposure is driven by factors such as increased remote work, online education, digital entertainment, and the growing reliance on technology for social interaction. Migraine treatment manages migraine symptoms triggered or worsened by extended screen time, including medications, lifestyle modifications, and the use of ergonomic practices to minimize strain and prevent attacks. For instance, in May 2024, according to the House of Commons Committee, a UK-based Parliament health agency, in 2021, children’s screen time increased by 52% in 2022, with nearly 25% of children and young people showing smartphone usage patterns consistent with behavioral addiction. Therefore, the prolonged screen exposure is driving the growth of the migraine treatment market.
Access Your Free Sample of the Global Migraine Treatment Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8126&type=smp
What is the projected market size of the migraine treatment industry, and how is it expected to grow?
The migraine treatment market size has grown strongly in recent years. It will grow from $3.18 billion in 2024 to $3.48 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increased prevalence of migraines, increased healthcare expenditure, improved formulations of existing drugs, expansion of clinical research, development of novel therapies.
The migraine treatment market size is expected to see rapid growth in the next few years. It will grow to $5.32 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to growing awareness and education, emergence of monoclonal antibodies, increasing focus on pediatric migraines, expansion of non-pharmacological interventions, global initiatives for migraine research. Major trends in the forecast period include advancements in therapeutic approaches, wearable devices and digital therapeutics, telemedicine and remote consultations, patient-centric care models, generic drug market growth, oral CGRP inhibitors.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8126&type=smp
Who are the key players driving competition in the migraine treatment market?
Major companies operating in the migraine treatment market are Pfizer Inc., Eli Lilly and Company, Amgen Inc., GlaxoSmithKline PLC, Novartis AG, Bayer AG, Allergan PLC, Abbott Laboratories, Allodynic Therapeutics LLC, AOBiome LLC, AstraZeneca PLC, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Limited, Impel Pharmaceuticals Inc., AbbVie Inc., Alder BioPharmaceuticals Inc., Astellas Pharma Inc., Biohaven Pharmaceutical Holding Company Ltd., Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Endo International PLC, Impax Laboratories Inc., Johnson & Johnson Inc., Lannett Company Inc., Lupin Limited, Merck & Co. Inc., Mylan N.V.
What key trends are expected to drive the micro-mobility charging infrastructure market during the forecast period?
Product innovations are the key trend gaining popularity in the migraine treatment market. Major companies operating in the market are introducing innovations such as liquid formulation to sustain their position in the market. For instance, in January 2022, BioDelivery Sciences International (BDSI), a US-based pharmaceutical company, launched Elyxyb (celecoxib oral solution), the acute treatment of migraines in adults, whether or not they experience aura. Its liquid formulation allows for rapid absorption in the small intestine, delivering faster relief compared to traditional tablets. This is especially beneficial for migraine sufferers who experience nausea or vomiting, as it eliminates the need to wait for a pill to dissolve. As the first and only FDA-approved ready-to-use oral solution for migraines, Elyxyb provides a more tolerable and efficient treatment option for managing the sudden, intense pain associated with migraines.
Which key geographies are driving the growth of the migraine treatment market?
North America was the largest region in the migraine treatment market in 2024. The regions covered in the migraine treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report
What are the key segments driving growth in the migraine treatment market?
The migraine treatment market covered in this report is segmented –
1) By Types: Episodic, Migraine With Aura, Chronic, Other Types
2) By Treatment: Acute Or Abortive Treatment, Preventive Or prophylactic Treatment, Non-Pharmacological Therapies And Devices
3) By End-User: Hospitals, Clinics, Homecare, Other End-users
Subsegments:
1) By Episodic: Frequent Episodic Migraine, Infrequent Episodic Migraine
2) By Migraine With Aura: Visual Aura, Sensory Aura, Speech Or Language Aura
3) By Chronic: Chronic Migraine Without Aura, Chronic Migraine With Aura
4) By Other Types: Hemiplegic Migraine, Retinal Migraine, Menstrual Migraine, Other Specific Types
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8126
How is the migraine treatment market defined, and what are its core characteristics?
A migraine is a neurological condition, with the most prominent symptom being a throbbing, pulsating headache on one side of the brain. Migraine treatment is used to treat a headache that often affects one side of the head and can be extremely painful, throbbing, or pulsating by blocking the pathways in the brain that cause pain. With the help of migraine treatment, future attacks and migraine symptoms can be stopped.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
